GGrantIndex
← Leaderboards

Mazhar Adli

University Of Virginia

$7,169,017
Attributed
$11,519,959
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY201725
$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,519,959 · 4

By mechanism

UM1$6,526,413 · 1
R01$4,993,546 · 3

Top collaborators

Most similar at University Of Virginia

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Genetic

Research focus

GeneticClustered Regularly Interspaced Short Palindromic RepeatsGenesCellsIn VitroResponseGene ExpressionMediatingChromatinBiologyTumorCell LineMolecularPhenotypeGenomeProgramsGenetic TranscriptionIn VivoRecurrenceClinically RelevantEpigenomicsEpigenetic ProcessEnhancersEpigenome

Grant awards (14)

Molecular and cellular characterization of essential human genes.$1,612,686
UM1 · FY2025 · HG · contact PI
Chemo-mediated transcriptional reprogramming in ovarian cancer$837,958
R01 · FY2025 · CA · contact PI
Modeling and Characterizing the Genomic Consequences of MED12 Mutations in Uterine Fibroids$688,000
R01 · FY2025 · HD · contact PI
Molecular and cellular characterization of essential human genes.$1,612,686
UM1 · FY2024 · HG · contact PI
Chemo-mediated transcriptional reprogramming in ovarian cancer$428,925
R01 · FY2024 · CA · contact PI
Molecular and cellular characterization of essential human genes.$1,631,251
UM1 · FY2023 · HG · contact PI
Chemo-mediated transcriptional reprogramming in ovarian cancer$452,366
R01 · FY2023 · CA · contact PI
Molecular and cellular characterization of essential human genes.$1,669,790
UM1 · FY2022 · HG · contact PI
Chemo-mediated transcriptional reprogramming in ovarian cancer$472,316
R01 · FY2022 · CA · contact PI
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer$413,874
R01 · FY2021 · CA · contact PI
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer$411,369
R01 · FY2020 · CA · contact PI
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer$426,739
R01 · FY2019 · CA · contact PI
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer$432,788
R01 · FY2018 · CA · contact PI
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer$429,211
R01 · FY2017 · CA · contact PI